Identification of novel dipeptidyl peptidase 9 substrates by two‐dimensional differential in‐gel electrophoresis

Dipeptidyl peptidase 9 (DPP9) is a member of the S9B/DPPIV (DPP4) serine protease family, which cleaves N‐terminal dipeptides at an Xaa‐Pro consensus motif. Cytoplasmic DPP9 has roles in epidermal growth factor signalling and in antigen processing, whilst the role of the recently discovered nuclear form of DPP9 is unknown. Mice lacking DPP9 proteolytic activity die as neonates. We applied a modified 2D differential in‐gel electrophoresis approach to identify novel DPP9 substrates, using mouse embryonic fibroblasts lacking endogenous DPP9 activity. A total of 111 potential new DPP9 substrates were identified, with nine proteins/peptides confirmed as DPP9 substrates by MALDI‐TOF or immunoblotting. Moreover, we also identified the dipeptide Val‐Ala as a consensus site for DPP9 cleavage that was not recognized by DPP8, suggesting different in vivo roles for these closely related enzymes. The relative kinetics for the cleavage of these nine candidate substrates by DPP9, DPP8 and DPP4 were determined. This is the first identification of DPP9 substrates from cells lacking endogenous DPP9 activity. These data greatly expand the potential roles of DPP9 and suggest different in vivo roles for DPP9 and DPP8.

[1]  Yiqian Chen,et al.  Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin. , 2015, Biochimica et biophysica acta.

[2]  O. Schilling,et al.  Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy , 2014, Proteomics. Clinical applications.

[3]  Zhihua Liu,et al.  S100 protein family in human cancer. , 2014, American journal of cancer research.

[4]  J. Pickard,et al.  Recombinant Human Interleukin-1 Receptor Antagonist in Severe Traumatic Brain Injury: A Phase II Randomized Control Trial , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  Ruth Geiss-Friedlander,et al.  The amino terminus extension in the long dipeptidyl peptidase 9 isoform contains a nuclear localization signal targeting the active peptidase to the nucleus , 2014, Cellular and Molecular Life Sciences.

[6]  Jolon M. Dyer,et al.  Evidence for the antagonistic form of CXC‐motif chemokine CXCL10 in serous epithelial ovarian tumours , 2014, International journal of cancer.

[7]  Yiqian Chen,et al.  Targeted Inactivation of Dipeptidyl Peptidase 9 Enzymatic Activity Causes Mouse Neonate Lethality , 2013, PloS one.

[8]  C. Lenz,et al.  The SUMO1-E67 Interacting Loop Peptide Is an Allosteric Inhibitor of the Dipeptidyl Peptidases 8 and 9* , 2013, The Journal of Biological Chemistry.

[9]  Yiqian Chen,et al.  Advances in Understanding the Expression and Function of Dipeptidyl Peptidase 8 and 9 , 2013, Molecular Cancer Research.

[10]  M. Kirby,et al.  DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues , 2013, Regulatory Peptides.

[11]  M. Condina,et al.  The utility of isotope-coded protein labeling for prioritization of proteins found in ovarian cancer patient urine. , 2013, Journal of proteome research.

[12]  W. Martinet,et al.  Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis , 2013, Basic Research in Cardiology.

[13]  T. Kawaguchi,et al.  Dipeptidyl peptidase-4: a key player in chronic liver disease. , 2013, World journal of gastroenterology.

[14]  C. Overall,et al.  Identifying Natural Substrates for Dipeptidyl Peptidases 8 and 9 Using Terminal Amine Isotopic Labeling of Substrates (TAILS) Reveals in Vivo Roles in Cellular Homeostasis and Energy Metabolism , 2013, The Journal of Biological Chemistry.

[15]  F. Melchior,et al.  A Novel SUMO1-specific Interacting Motif in Dipeptidyl Peptidase 9 (DPP9) That Is Important for Enzymatic Regulation* , 2012, The Journal of Biological Chemistry.

[16]  J. Gathercole,et al.  The emerging role of CXC chemokines in epithelial ovarian cancer. , 2012, Reproduction.

[17]  Yuquan Wei,et al.  Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels. , 2012, Oncology reports.

[18]  S. Unniappan,et al.  Nucleobindins: bioactive precursor proteins encoding putative endocrine factors? , 2012, General and comparative endocrinology.

[19]  D. Schuppan,et al.  When GLP-1 hits the liver: a novel approach for insulin resistance and NASH. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[20]  A. Zekry,et al.  The long and the short of interferon‐gamma–inducible protein 10 in hepatitis C virus infection , 2011, Hepatology.

[21]  P. Quax,et al.  The isoenzyme of glutaminyl cyclase is an important regulator of monocyte infiltration under inflammatory conditions , 2011, EMBO molecular medicine.

[22]  Jason U Tilan,et al.  Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors , 2011, The Journal of Biological Chemistry.

[23]  Kang-Yell Choi,et al.  A Novel Role of Dipeptidyl Peptidase 9 in Epidermal Growth Factor Signaling , 2011, Molecular Cancer Research.

[24]  A. Saghatelian,et al.  A peptidomics strategy to elucidate the proteolytic pathways that inactivate peptide hormones. , 2011, Biochemistry.

[25]  A. Casrouge,et al.  Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. , 2011, The Journal of clinical investigation.

[26]  P. Nicholls,et al.  Post-translational modifications and protein-specific isoforms in endometriosis revealed by 2D DIGE. , 2010, Journal of proteome research.

[27]  A. Saghatelian,et al.  Expanding the dipeptidyl peptidase 4-regulated peptidome via an optimized peptidomics platform. , 2010, Journal of the American Chemical Society.

[28]  J. Bines,et al.  Proteomic analysis of the intestinal adaptation response reveals altered expression of fatty acid binding proteins following massive small bowel resection. , 2010, Journal of proteome research.

[29]  Y. Li,et al.  Proteomic identification of caldesmon as a physiological substrate of proprotein convertase 6 in human uterine decidual cells essential for pregnancy establishment. , 2009, Journal of proteome research.

[30]  C. Abbott,et al.  The In Vivo Expression of Dipeptidyl Peptidases 8 and 9 , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  H. Urlaub,et al.  The Cytoplasmic Peptidase DPP9 Is Rate-limiting for Degradation of Proline-containing Peptides* , 2009, The Journal of Biological Chemistry.

[32]  A. Tomida,et al.  A Novel Endoplasmic Reticulum Export Signal , 2009, The Journal of Biological Chemistry.

[33]  Xin Chen,et al.  Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor. , 2009, Biochemical pharmacology.

[34]  B. Honoré The rapidly expanding CREC protein family: members, localization, function, and role in disease , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[35]  M. Kirby,et al.  Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition. , 2009, Clinical science.

[36]  W. B. Church,et al.  Reversible Inactivation of Human Dipeptidyl Peptidases 8 and 9 by Oxidation , 2008 .

[37]  B. S. Hamilton,et al.  Expression and characterization of human glycosylated interleukin-1 receptor antagonist in Pichia pastoris. , 2008, Protein expression and purification.

[38]  C. Overall,et al.  Stromal cell‐derived factors 1α and 1β, inflammatory protein‐10 and interferon‐inducible T cell chemo‐attractant are novel substrates of dipeptidyl peptidase 8 , 2008, FEBS letters.

[39]  F. Melchior,et al.  Concepts in sumoylation: a decade on , 2007, Nature Reviews Molecular Cell Biology.

[40]  Yusuke Nakamura,et al.  Nucleobindin 1 Controls the Unfolded Protein Response by Inhibiting ATF6 Activation* , 2007, Journal of Biological Chemistry.

[41]  G. McCaughan,et al.  Extraenzymatic functions of the dipeptidyl peptidase IV‐related proteins DP8 and DP9 in cell adhesion, migration and apoptosis , 2006, The FEBS journal.

[42]  P. F. Nielsen,et al.  Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV. , 2006, The Biochemical journal.

[43]  M. Gorrell Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. , 2005, Clinical science.

[44]  E. Friauf,et al.  A subcellular prefractionation protocol for minute amounts of mammalian cell cultures and tissue , 2005, Proteomics.

[45]  Kathryn S Lilley,et al.  All about DIGE: quantification technology for differential-display 2D-gel proteomics , 2004, Expert review of proteomics.

[46]  A. Imberty,et al.  Heparan Sulfate/Heparin Oligosaccharides Protect Stromal Cell-derived Factor-1 (SDF-1)/CXCL12 against Proteolysis Induced by CD26/Dipeptidyl Peptidase IV* , 2004, Journal of Biological Chemistry.

[47]  C. Abbott,et al.  Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity. , 2004, Biochimica et biophysica acta.

[48]  M. Friedlander,et al.  Lacryglobin in human tears, a potential marker for cancer , 2001, Clinical & experimental ophthalmology.

[49]  N. Tanuma,et al.  Up-regulation of I-2(PP2A)/SET gene expression in rat primary hepatomas and regenerating livers. , 2000, Cancer letters.

[50]  G. Opdenakker,et al.  Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. , 1998, Biochemistry.